Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Functionally specialized junctions between endothelial cells of lymphatic vessels
2007 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Stress-induced ST-segment elevation in patients without prior Q-wave myocardial infarction
2008
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
2005
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Stroke Prevention by Cilostazol in Patients with Atherothrombosis: Meta-analysis of Placebo-controlled Randomized Trials
2009
Mechanobiology and diseases of mechanotransduction
2003
Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P
2003 Nobel
Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta
2003
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Exercise Standards for Testing and Training
2013 Standout
Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
2012
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Physiological role of ROCKs in the cardiovascular system
2006
Early exercise testing after acute myocardial infarction in the elderly: Clinical evaluation and prognostic significance
1993
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Development of specific Rho-kinase inhibitors and their clinical application
2005
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
2002
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
The immune system in atherosclerosis
2011 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Microfluidic organs-on-chips
2014 Standout
Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease
2010
Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix
2009 Standout
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
2007
Prevention of Ventricular Fibrillation by Cilostazol, an Oral Phosphodiesterase Inhibitor, in a Patient with Brugada Syndrome
2002
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Myocardial Reperfusion Injury
2007 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Atherosclerosis
2019 Standout
U Wave: Facts, Hypotheses, Misconceptions, and Misnomers
1998
Third Universal Definition of Myocardial Infarction
2012 Standout
The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
2009
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
2016
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
2007 Standout
Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures
1997 Standout
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
1999
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
2003
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes
2007 StandoutNobel
Candesartan and Insulin Reduce Renal Sympathetic Nerve Activity in Hypertensive Type 1 Diabetic Rats
2008
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Biomarkers in Heart Failure
2008 Standout
Left ventricular flow propagation during early filling is related to wall relaxation: A color M-mode Doppler analysis
1992
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis
2004
Supramolecular biomaterials
2015 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009
A randomized study comparing propranolol and diltiazem in the treatment of unstable angina
1985
Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure
2007
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
Correlation of Antemortem Serum Creatine Kinase, Creatine Kinase-MB, Troponin I, and Troponin T with Cardiac Pathology
2000
Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure
2003
Targeting Interleukin-1 in Heart Disease
2013
Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges
2005
Ambulatory electrocardiography and the diagnosis, evaluation, and treatment of chronic ventricular arrhythmias
1980
Heart Failure
2003
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Novel markers for heart failure diagnosis and prognosis
2005
Prognostic significance of the electrocardiogram after Q wave myocardial infarction. The Framingham Study.
1990
Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats
2004
Rho‐associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts
2008
Mechanisms of Diabetic Complications
2013 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Superoxide Ion: Generation and Chemical Implications
2016 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Inflammatory Cytokines Stimulate Adrenomedullin Expression Through Nitric Oxide–Dependent and –Independent Pathways
2002
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Severe Acquired Toxoplasmosis in Immunocompetent Adult Patients in French Guiana
2002
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Applications of the luminol chemiluminescent reaction in analytical chemistry
2006
Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis
2013
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Hypoxia Inducible Factor 1 Mediates Hypoxia-Induced TRPC Expression and Elevated Intracellular Ca 2+ in Pulmonary Arterial Smooth Muscle Cells
2006 StandoutNobel
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Works of Hiroshi Kishida being referenced
Chronotropic Effects of Cilostazol, a New Antithrombotic Agent, in Patients with Bradyarrhythmias
1998
Real-time measurement of nitric oxide by luminol-hydrogen peroxide reaction in crystalloid perfused rat heart
2002
Osborn Waves Associated with Ventricular Fibrillation in a Patient with Vasospastic Angina
2002
Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure
1999
Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy
1997
Anti-anginal Effect of Fasudil, a Rho-Kinase Inhibitor, in Patients With Stable Effort Angina: A Multicenter Study
2002
Clinical significance of increased plasma concentration of macrophage colony–stimulating factor in patients with angina pectoris
2000
Mutual information discloses relationship between hemodynamic variables in artificial heart-implanted dogs
1998
Lack of antagonism between nicorandil and sulfonylurea in stable angina pectoris.
2001
[Detection of myocardial ischemia by analysis of the shape of exercise-induced ST elevation in infarct-related leads].
2004
Prognostic value of second generation cardiac troponin T in patients with chronic heart failure
1998
Vasodilatory Effect of Subsequent Administration of Fasudil, a Rho-Kinase Inhibitor, Surpasses That of Nitroglycerin at the Concentric Coronary Stenosis in Patients With Stable Angina Pectoris
2006
Variant Angina and Coronary Artery Spasm: The Clinical Spectrum, Pathophysiology, and Management
2011
Negative U wave: A highly specific but poorly understood sign of heart disease
1982
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.
1981
[Toxoplasma pericarditis without immunosuppressant disorder detected by polymerase chain reaction of pericardial fluid: a case report].
2000
Prognostic value of low-level exercise testing in patients with myocardial infarction.
1989
Prognosis of patients with persistent negative U wave following myocardial infarction.
1987
Effects of a Single Oral Dose of Cilostazol on Epicardial Coronary Arteries and Hemodynamics in Humans.
2002
Review of the pocket-electrocardiograph (PECG) in a large general medical clinic.
1976